Literature DB >> 29241168

Epidemiology of Intracranial Gliomas.

Quinn T Ostrom, Haley Gittleman, Lindsay Stetson, Selene Virk, Jill S Barnholtz-Sloan.   

Abstract

Gliomas are the most common primary intracranial neoplasms, which cause significant mortality and morbidity that is disproportionate to their relatively rare incidence. Many potential risk factors for glioma have been studied to date, but only few provide explanation for the number of brain tumor cases identified. The most significant findings include increased risk due to exposure to ionizing radiation and decreased risk with the history of allergy or atopic diseases. The potential effect of the cellular phone usage has been evaluated extensively, but the results remain inconclusive. A very small proportion of gliomas can be attributed to inherited genetic disorders. Additionally, recent analyses using the genome-wide association study design have identified several inherited genomic risk variants.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 29241168     DOI: 10.1159/000464374

Source DB:  PubMed          Journal:  Prog Neurol Surg        ISSN: 0079-6492


  27 in total

Review 1.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

2.  Genetic Predisposition to Glioma Mediated by a MAPKAP1 Enhancer Variant.

Authors:  Liming Huang; Wenshen Xu; Danfang Yan; Xin You; Xi Shi; Shu Zhang; Hualan Hong; Lian Dai
Journal:  Cell Mol Neurobiol       Date:  2019-11-26       Impact factor: 5.046

3.  BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.

Authors:  Bo Wang; Chen Cao; Xi Liu; Xin He; Hao Zhuang; Dong Wang; Budong Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-27       Impact factor: 6.730

4.  Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.

Authors:  Marta Viana-Pereira; Daniel Antunes Moreno; Paulo Linhares; Júlia Amorim; Rui Nabiço; Sandra Costa; Rui Vaz; Rui Manuel Reis
Journal:  Mol Biol Rep       Date:  2019-11-12       Impact factor: 2.316

Review 5.  Radiomics can differentiate high-grade glioma from brain metastasis: a systematic review and meta-analysis.

Authors:  Yuanzhen Li; Yujie Liu; Yingying Liang; Ruili Wei; Wanli Zhang; Wang Yao; Shiwei Luo; Xinrui Pang; Ye Wang; Xinqing Jiang; Shengsheng Lai; Ruimeng Yang
Journal:  Eur Radiol       Date:  2022-05-19       Impact factor: 5.315

6.  Do Cell Phones Cause Brain Tumors? Another Piece of the Puzzle.

Authors:  Douglas L Weed
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

7.  Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.

Authors:  Lingyang Xia; Peng Jin; Wei Tian; Shuang Liang; Liye Tan; Binxin Li
Journal:  Braz J Med Biol Res       Date:  2021-05-17       Impact factor: 2.590

8.  ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.

Authors:  Houshi Xu; Anke Zhang; Xiaying Han; Yanning Li; Zeyu Zhang; Liying Song; Wei Wang; Meiqing Lou
Journal:  Cancer Immunol Immunother       Date:  2021-07-27       Impact factor: 6.968

9.  Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.

Authors:  José Alberto Carlos-Escalante; Liliana Gómez-Flores-Ramos; Xiaopeng Bian; Alexander Perdomo-Pantoja; Kelvin César de Andrade; Sonia Iliana Mejía-Pérez; Bernardo Cacho-Díaz; Rodrigo González-Barrios; Nancy Reynoso-Noverón; Ernesto Soto-Reyes; Thalía Estefanía Sánchez-Correa; Lissania Guerra-Calderas; Chunhua Yan; Qingrong Chen; Clementina Castro-Hernández; Silvia Vidal-Millán; Lucía Taja-Chayeb; Olga Gutiérrez; Rosa María Álvarez-Gómez; Juan Luis Gómez-Amador; Patricia Ostrosky-Wegman; Alejandro Mohar-Betancourt; Luis Alonso Herrera-Montalvo; Teresa Corona; Daoud Meerzaman; Talia Wegman-Ostrosky
Journal:  Cell Mol Neurobiol       Date:  2020-06-13       Impact factor: 5.046

10.  KLF11 Expression Predicts Poor Prognosis in Glioma Patients.

Authors:  Zhuo Xi; Rui Zhang; Furong Zhang; Shuang Ma; Tianda Feng
Journal:  Int J Gen Med       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.